What’s more, overall survival (OS), progression-free interval (PFI) and disease specific survival (DSS) curves of AKR1B1 in pan-cancer from TCGA database showed that tumor patients with high expression of AKR1B1 had worse prognosis (Fig. 1B). The gene discussed is AKR1B1; the disease is neoplasm.